Your support helps us to tell the story
From reproductive rights to climate change to Big Tech, The Independent is on the ground when the story is developing. Whether it's investigating the financials of Elon Musk's pro-Trump PAC or producing our latest documentary, 'The A Word', which shines a light on the American women fighting for reproductive rights, we know how important it is to parse out the facts from the messaging.
At such a critical moment in US history, we need reporters on the ground. Your donation allows us to keep sending journalists to speak to both sides of the story.
The Independent is trusted by Americans across the entire political spectrum. And unlike many other quality news outlets, we choose not to lock Americans out of our reporting and analysis with paywalls. We believe quality journalism should be available to everyone, paid for by those who can afford it.
Your support makes all the difference.An easy-to-use blood-clotting drug that costs just a few dollars could save up to 100,000 lives each year from road accidents and violence, according to a paper published on Tuesday by The Lancet.
Doctors at the London School of Hygiene and Tropical Medicine tested an off-patent treatment called tranexamic acid (TXA) among 20,000 severely-injured adults in 274 hospitals in 40 countries.
Participants received either one gram of TXA by injection followed by another one gram in a drip over the following eight hours, or a dummy lookalike.
TXA reduced the risk of death by any cause by 10 percent compared with the placebo, the paper said.
When it came to the risk of death by bleeding, TXA scored a reduction of 15 percent over the placebo.
Each year, more than a million people die as a result of traffic injuries, and another 1.6 million die as a result of acts of violence, and many could be saved by swift action to stop haemorrhaging, the researchers said.
"Each year about 600,000 injured patients bleed to death worldwide," said lead author Ian Roberts, a professor of epidemiology.
"Injuries may be accidental, for example, road crashes, or intentional, such as shootings, stabbings or land-mine injuries, and the majority of deaths occur soon after injury."
TXA works by reducing the breakdown of clots. The drug is manufactured by a number of companies, and a gram of it costs about 4.50 dollars.
If TXA became widely available and was used promptly, it could save as many as 100,000 lives a year, 13,000 of them in India and 12,000 in China, where road deaths are surging, the paper said.
"The drug is inexpensive and could be given in hospitals worldwide," said Etienne Krug, director of violence and injury prevention and disability at the UN's World Health Organisation (WHO).
"It is essential that doctors are aware of these results and take them into account in the emergency management of seriously injured patients."
The trial was carried out to see whether TXA was effective and whether it had bad side effects, such as increasing the risk of heart attacks, strokes and lung clots.
On the latter score, there was no increase in any of these complications, the authors said.
Join our commenting forum
Join thought-provoking conversations, follow other Independent readers and see their replies
Comments